Chris Martenson: Best Covid Treatment To Date By Far!

Peak Prosperity, Released on 12/3/20

The data is 100% in agreement: All studies show a clinical benefit for use of Ivermectin. It works as a pre-exposure prophylaxis, post exposure prophylaxis, and when given to both early and late hospitalized patients. As importantly, one study shows a profound improvement in the symptoms for the “long haul” Covid sufferers, for which no other treatments seem to have worked. If you think you’ve been exposed, or have been exposed, or work in a high risk situation, or you have Covid symptoms, or you are a long haul suffere, the data is clear: take Ivermectin immediately. The sooner the better. As is always true of an antiviral. Or antibiotic. That should be crystal clear to everyone except the designers of the tragic RECOVERY trial in the UK, and various W.H.O. study designers. They seem to be a bit dense on the topic for *cough$$$*cough some unknown reason$. If your health provider won’t provide Ivermectin, then go elsewhere. You have a quack, or a slow learner on your hands, not an up-to-date doc.

Links: Ivermectin Meta Data https://ivmmeta.com/

Meta Review of Ivermectin (Pre-Print) – This is MEGA IMPORTANT! https://osf.io/wx3zn/

Ivermectin in Mexico https://www.sie7edechiapas.com/post/r…

Ivermectin in Romania https://www.smartradio.ro/covid-19-iv…

Christopher Martenson is a former American biochemical scientist. Currently he is a writer and trend forecaster interested in macro trends regarding the economy, energy composition and environment. He is the founder of PeakProsperity.com. As one of the early econobloggers who forecasted the housing market collapse and stock market correction years in advance, Chris rose to prominence with the launch of his seminal video seminar which later became a book called The Crash Course. Chris’ latest book (co-authored with Adam Taggart) is called Prosper!: How to Prepare for the Future and Create a World Worth Inheriting.

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments